Intel Corp. announced its now former CEO Pat Gelsinger, who spent most of his more than 40-year career with the Santa Clara, California-based semiconductor manufacturer, had retired on Dec. 1.
Gelsinger, who took over as Intel’s chief executive in February 2021, pushed it to begin making chips for other semiconductor companies while simultaneously designing and manufacturing its own chips. His plan cost billions and has yet to deliver results.
In a Monday release, Intel said it had appointed David Zinser, an executive vice president, and CFO Michelle Johnston Holthaus, the CEO of Intel Products, as interim co-CEOs while the company’s board of directors searches for a new CEO.
The change initially sent Intel’s stock price up as high as $25.44 a share, but as of Tuesday afternoon, it had sagged back to about $22.50 a share. Since the beginning of August, it has hovered around the $20 per share mark. Since the beginning of 2024, its value has fallen by about 55 percent.
In addition, Intel’s stock is currently trading for less than half of the $58.18 it closed at on Jan. 31, 2021. Following its nearly three-year bear run, Intel received a significant downgrade in November when it was replaced on the Dow Jones Industrial Average (DJIA) by rival chipmaker Nvidia Corp. At the time, Intel had the lowest stock price of any of the companies in the DJIA. […]
— Read More: www.theepochtimes.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.
